Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noradrenaline, Acetylcholine and Dynamic Learning in Healthy Humans
NCT03957174Completed
- Sponsor
- University of Oxford
- Start
- Jun 2019
- Primary completion
- Jun 2020
- Modality
- Reversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of reboxetine and rivastigmine, sponsored by University of Oxford. Primary endpoint: Change in learning rates at 2 hours. Started Jun 2019; status: completed.
02
Drugs
reboxetinerivastigmine
Beyond the preview
Go deeper on NCT03957174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03957174.